Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells.
about
Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatmentGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskThe ZNF304-integrin axis protects against anoikis in cancerMeta-analytical biomarker search of EST expression data reveals three differentially expressed candidates.Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry.Stem cells in aged mammalian ovariesLaser capture microdissection (LCM) and whole genome amplification (WGA) of DNA from normal breast tissue --- optimization for genome wide array analysesDifferential co-expression analysis reveals a novel prognostic gene module in ovarian cancer2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.Genetic variants in TGF-β pathway are associated with ovarian cancer risk.β-catenin/Tcf-signaling appears to establish the murine ovarian surface epithelium (OSE) and remains active in selected postnatal OSE cells.VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancerReinterpretation of evidence advanced for neo-oogenesis in mammals, in terms of a finite oocyte reserveSimilarity of markers identified from cancer gene expression studies: observations from GEOScreening of feature genes of the ovarian cancer epithelia with DNA microarrayDynamics of the primate ovarian surface epithelium during the ovulatory menstrual cycleOvarian surface epitheliectomy in the non-human primate: continued cyclic ovarian function and limited epithelial replacement.Ovarian cancer stem cells: are they real and why are they important?Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes.Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer.Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.Transcriptional override: a regulatory network model of indirect responses to modulations in microRNA expressionmiR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.Article by Natalie Banet and Robert J. Kurman: Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis; Int. J. Gynecol. Pathol. 2015;34:3-8Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy.Ovarian surface epithelium in patients with severe ovarian infertility: a potential source of cells expressing markers of pluripotent/multipotent stem cells.BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer.The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer.Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets.The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer.Germline cells in ovarian surface epithelium of mammalians: a promising notion.Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancerFunctional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status.RETRACTED: Investigation of the hub genes and related mechanism in ovarian cancer via bioinformatics analysis.HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.Screening of potentially crucial genes and regulatory factors involved in epithelial ovarian cancer using microarray analysisMetformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer.
P2860
Q26829125-C99F9F95-C019-4496-9324-654AE595E69FQ27008356-E3D547F4-E48D-4864-821D-DAA072C7153FQ28115264-4158771A-DA74-485C-B9E5-E81BB0600039Q30584141-34B347E4-5669-46E2-A72D-96916AD15FCCQ33630878-B1B45A8D-5E71-45D2-9AB7-678F4D6F48F7Q33722175-1930A07C-A281-4A21-8988-C0D65379CD6AQ33850268-95E3C782-BF7E-410A-AF7A-949ED15A3D15Q33890351-232ACD2D-8828-4913-8A36-EDDA8E45237FQ33956803-3135E1A9-5422-4AD0-BF90-E2D0CF97F888Q34044950-26F424F4-6C02-45C2-B046-E3D444DB9AC0Q34298272-B212FC3D-9FA6-45FB-BF24-FA43B112F0ACQ34328133-0E2F5CFE-1D45-4D9C-8FF6-ADE9C4A05984Q34510690-B7DE0141-3ADC-4A6A-971B-2399DA1BB990Q34736426-4F41CAD6-F201-49FD-9622-D45EEDB2762BQ34759643-59C7D5CF-879B-41D1-8319-806B9D296481Q34987370-2428300F-BD31-499D-B44F-6932778C59DBQ34987376-979E7103-4839-49E1-A790-9AD63A3D37A2Q35047699-A390A942-AF7C-4725-84D9-20E9C6739D56Q35058483-042C1F87-2A0A-4AA3-94CA-E8216AF654B4Q35079572-BD34F21F-73AD-43B8-9C7C-0EB0AA64909BQ35116008-1E04EBA0-BF65-42AF-A9DC-BB9C82DB9BA0Q35130693-688F832A-1241-4AAA-BB18-7DB5A0D22259Q35177212-D7A14EFC-0D36-4A90-82CA-0334F782732BQ35580717-2A43B43E-1A4D-4863-88B8-AE758E6452B5Q35600183-26CEB808-F343-4A9B-9CE4-93B84DB0D76AQ35610472-A92DBCCA-1797-4724-BF71-1F926BF0246FQ35723745-8FB18163-6ACB-4014-8DCC-6383EA637669Q36091016-267B7114-1CCE-41C6-B875-6E9A6DFAA030Q36424741-E920CAD1-541A-4246-B601-3103629BE9C4Q36588945-2814DC4E-54C1-4FD7-8500-E73FD10D4942Q36594506-ACCD98E3-B434-45AA-A235-6EA9D4D39C2DQ36691897-388A4023-8A07-4428-912C-CFD45ED56464Q36938409-8E049287-9D65-4264-9090-25C3D57450F6Q37040827-A96A1EA1-B4FB-4871-B421-6E46CA6B3FF3Q37223322-159FCD68-D096-4CAC-B34A-341632207524Q37479727-D952E99E-5414-4F0B-B6DE-5ADAFE87EDD8Q37688836-492B7CCF-E6B3-4B2A-94E7-4783260F20DBQ38034167-7BF100EB-3594-49B2-B352-46D4E8B8A24DQ38686022-C4CA32FD-7A8E-4851-8782-0A61F7912274Q38774498-7FA01D3C-7F1D-4888-B155-22476DFDEC5D
P2860
Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Gene expression profiling supp ...... arian cancer initiating cells.
@ast
Gene expression profiling supp ...... arian cancer initiating cells.
@en
Gene expression profiling supp ...... arian cancer initiating cells.
@nl
type
label
Gene expression profiling supp ...... arian cancer initiating cells.
@ast
Gene expression profiling supp ...... arian cancer initiating cells.
@en
Gene expression profiling supp ...... arian cancer initiating cells.
@nl
prefLabel
Gene expression profiling supp ...... arian cancer initiating cells.
@ast
Gene expression profiling supp ...... arian cancer initiating cells.
@en
Gene expression profiling supp ...... arian cancer initiating cells.
@nl
P2093
P2860
P356
P1433
P1476
Gene expression profiling supp ...... arian cancer initiating cells.
@en
P2093
Benedict B Benigno
John F McDonald
Kimberly A Totten
L DeEtte Walker
Lilya V Matyunina
Sanjay Logani
P2860
P2888
P356
10.1186/1755-8794-2-71
P577
2009-12-29T00:00:00Z
P5875
P6179
1037148151